OPKO Health
OPK
#6036
Rank
NZ$1.66 B
Marketcap
NZ$2.09
Share price
-1.56%
Change (1 day)
-21.51%
Change (1 year)

Earnings for OPKO Health (OPK)

Earnings in 2025 (TTM): -NZ$0.27 Billion

According to OPKO Health 's latest financial reports the company's current earnings are NZ$0.64 Billion. In 2024 the company made an earning of -NZ$17.21 Million, an increase over its 2023 earnings that were of -NZ$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OPKO Health from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.27 Billion1426.11%
2024 -NZ$17.21 Million-94.38%
2023 -NZ$0.31 Billion-52.92%
2022 -NZ$0.66 Billion2691.58%
2021 -NZ$23.3 Million-128.81%
2020 NZ$80.84 M-115.96%
2019 -NZ$0.51 Billion72.03%
2018 -NZ$0.3 Billion-33.83%
2017 -NZ$0.45 Billion264.29%
2016 -NZ$0.13 Billion-46.71%
2015 -NZ$0.23 Billion-19.31%
2014 -NZ$0.29 Billion64.11%
2013 -NZ$0.18 Billion180.06%
2012 -NZ$61.8 Million53.56%
2011 -NZ$40.25 Million55.87%
2010 -NZ$25.83 Million-48.27%
2009 -NZ$49.92 Million-24.64%
2008 -NZ$66.23 Million-85.11%
2007 -NZ$0.45 Billion6.61%
2006 -NZ$0.42 Billion18539.02%
2005 -NZ$2.24 Million-32.33%
2004 -NZ$3.31 Million-45.53%
2003 -NZ$6.08 Million-64.7%
2002 -NZ$17.21 Million2.99%
2001 -NZ$16.71 Million16.9%
2000 -NZ$14.29 Million104.81%
1999 -NZ$6.98 Million40.03%
1998 -NZ$4.99 Million-0%
1997 -NZ$4.99 Million7.14%
1996 -NZ$4.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.80 B-20,413.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.51 B-5,202.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.54 B-3,326.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.34 B-5,137.03%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.21 B-935.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.21 B-181.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.94 B-1,211.12%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-NZ$92.26 Million-65.17%๐Ÿ‡บ๐Ÿ‡ธ USA